NCT05877157

Brief Summary

The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week after surgery (or discharge, whichever is earlier), and up to the end of the postoperative year. Additional secondary outcomes are the incidence of preoperative pain, persistent pain with/without the presence of neuropathic components, quality of life and surgical complications. The potential association between opioid use and pain outcomes will be investigated. This study could help to develop strategies to improve quality of care, through pain management, for patients undergoing surgery.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Sep 2023

Typical duration for all trials

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Sep 2023Sep 2026

First Submitted

Initial submission to the registry

April 6, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 26, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 25, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

2.7 years

First QC Date

April 6, 2023

Last Update Submit

December 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient reported Opioid use post surgery

    Patient reported use of opioids post surgery

    3 months

Secondary Outcomes (6)

  • Opioid use

    From recruitment to 1 year post surgery

  • Patient reported incidence of pain pre-op and post surgery using BPI-SF

    From recruitment to 1 year post surgery

  • Patient reported incidence of pain pre-op and post surgery using DN2

    From recruitment to 1 year post surgery

  • Surgical complications

    During surgery

  • Participant reported quality of life EQ5D-5L

    From recruitment to 1 year post surgery

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All eligible patients undergoing surgery at the hospital during the designated study week

You may qualify if:

  • hospitalised adult patients (18 years and older) undergoing any inpatient surgery (elective or emergency) during the designated study week where an anaesthetist is involved (general anaesthetic, sedation, local anaesthetic).
  • Able to understand and has capacity to give written informed consent

You may not qualify if:

  • American Society of Anaesthesiologists (ASA) grade V or VI
  • Refusal to participate.
  • Lack of comprehension of validated questionnaires or inability to complete the follow-up for any reason.
  • Lack of capacity to give written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of Anaesthesiology Sestre Milosrdnice, University Hospital Center

Zagreb, Vinogradska 29, 10000, Croatia

NOT YET RECRUITING

NHS Grampian

Aberdeen, United Kingdom

RECRUITING

University College London Hospitals NHS Foundation Trust

London, United Kingdom

ACTIVE NOT RECRUITING

Kings Mill Hospital, Sherwood Forest Hospitals NHS Foundation Trust

Nottingham, United Kingdom

ACTIVE NOT RECRUITING

MeSH Terms

Conditions

Chronic PainPain, Postoperative

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Patrice Forget

    University of Aberdeen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Holly R Keir, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2023

First Posted

May 26, 2023

Study Start

September 25, 2023

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

December 24, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations